AnnMarieNavarMDPhD, FACC, FAHA, FASCP

Cardiology • Dallas, TX

Preventive Cardiology

Physician

Join to view full profile

Dr. Navar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Navar's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-633-5555

Fax+1 214-645-6757

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 2013 - 2016
Duke University HospitalResidency, Internal Medicine/Pediatrics, 2009 - 2013
Duke University School of MedicineClass of 2009

Certifications & Licensure

TX State Medical License 2020 - 2026
NC State Medical License 2009 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Associations of a Composite Stress Measurement Tool With Cardiovascular Risk Factors and Outcomes: Findings From the Dallas Heart Study.
Ijeoma Eleazu, Colby Ayers, Ann Marie Navar, Karim Salhadar, Michelle Albert
Journal of the American Heart Association. 2025-03-04
Achievement of guideline-based lipid goals among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: results in 213,380 individual...
Satoshi Shoji, Nishant P Shah, Peter Shrader, Laine E Thomas, Jonathan D Arnold
American Journal of Preventive Cardiology. 2025-03-01
Impact of payer rejections and out-of-pocket costs on patient access to bempedoic acid therapy.
Jimin Hwang, Eric Peterson, Anand Gupta, Evelyn Sarnes, Kristin Gillard
American Journal of Preventive Cardiology. 2025-03-01

Journal Articles

Choosing an Initial Therapeutic Approach for Hypertension—Time for a Fixed-Dose Combination First?
Ann Marie Navar, Thomas J Wang, JAMA Cardiology
Heroism in the Face of the COVID-19 Pandemic
Ajay J Kirtane, Ann Marie Navar, JAMA Cardiology
Moving Beyond Regression Techniques in Cardiovascular Risk Prediction: Applying Machine Learning to Address Analytic Challenges
Ann Navar, MD, European Heart Journal

Abstracts/Posters

[Board 414] Triglycerides as a Risk Factor For Coronary Heart Disease: What Measure and What Cutoff?
Ann Navar, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/18/2019

Lectures

Deep Dive II
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Authored Content

How Real-World Data Augments What We Know About SGLT-2 Inhibitors for Cardiovascular Risk ReductionSeptember 2020
Choosing an Initial Therapeutic Approach for Hypertension—Time for a Fixed-Dose Combination First?July 2020
Heroism in the Face of the COVID-19 PandemicJune 2020

Press Mentions

AHA’s 2025 Heart Disease and Stroke Update Brings Good and Bad NewsFebruary 3rd, 2025
Apolipoprotein B Test May Be More Accurate Measure of Heart Disease RiskAugust 14th, 2024
Pregnant Cardiology Trainees Report High Complication Rates, Lack of Radiation SafetyAugust 9th, 2024
Join now to see all

Other Languages

Spanish